Precision fermented functional lipids sales will expand through 2035, with omega-3 fatty acids at 36.0% of lipid type demand, dietary supplements and nutraceuticals at 35.0% of application sales and algae-derived lipids at 40.0% within the source microorganism segment in 2025. The market is projected to record a 5.8% CAGR between 2025 and 2035.